Generic Drugs Used More In Part D Than Commercial Market
A key benchmark of plan performance -- the use of generic medications -- is higher in Medicare Part D than in the rest of the marketplace.
Part D plans have also helped previously uninsured seniors to reduce their out-of-pocket costs by 60 percent per prescription according to IMS.
The new IMS report-Medicare Part D: The First Year-examines the impact of Part D on medication use among seniors. Specifically, IMS finds:
-- Generic drugs comprise 58 percent of prescriptions in Part D, compared to 57 percent of all retail prescriptions;
-- In Part D, patient compliance with therapies for chronic conditions increased in 4 out of 5 therapeutic categories;
-- Previously uninsured seniors in Part D increased their use of all medications-including both generics and brands-by